- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Cavan Ventures Inc. (TSXV:CVN) announced its plans to conduct diamond drilling programs in Q2 at its Buckingham and Tetepiska-East graphite properties in Quebec. The Company also announced that it will be working with Robson Capital Markets Advisory on financing and potential opportunities in the medical marijuana space.
Cavan Ventures Inc. (TSXV:CVN) announced its plans to conduct diamond drilling programs in Q2 at its Buckingham and Tetepiska-East graphite properties in Quebec. The Company also announced that it will be working with Robson Capital Markets Advisory on financing and potential opportunities in the medical marijuana space.
As quoted in the press release:
Cavan intends to conduct diamond drilling programs in Q2 2014 at its 100%-owned Buckingham and Tetepiska-East graphite properties, located in western and northeastern Quebec, respectively (see PR dated January 22, 2014).
To assist in funding these drill programs, Cavan is pleased to announce that it has engaged Robson Capital Markets Advisory, a Vancouver based corporate advisory and EMD, to lead an upcoming non brokered financing. Further information regarding such financing will be announced as they are determined. Robson Capital Markets Advisory will also advise Cavan in its further investigation and analysis of the medical marijuana space and potential opportunities therein.
Cavan Ventures President and CEO, Peter Swistak, said:
We are very excited to start working with Robson Capital and are moving ahead in a timely manner towards further development of our graphite interests. We are also carefully investigating and exploring potential opportunities in the medical marijuana sector, and look forward to working with Robson Capital in that regard as well.
Click here to read the Cavan Ventures Inc. (TSXV:CVN) press release
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Â